An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
NCT06414317 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2026-01-29
Summary
This clinical trial evaluates the impact of an education and navigation support tool (ENST) on patient and caregiver participation in care coordination for bladder cancer that has spread to nearby tissue or lymph nodes (locally advanced), to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Patients with advanced bladder cancer tend to be older, have multiple medical conditions and often have poor access to health care. An ENST may be an effective method to improve participation in treatment decision-making and care planning among patients with locally advanced, metastatic and unresectable bladder cancer and their caregivers.
Conditions
- Locally Advanced Bladder Carcinoma
- Metastatic Bladder Carcinoma
- Stage III Bladder Cancer AJCC v8
- Stage IV Bladder Cancer AJCC v8
- Unresectable Bladder Carcinoma
Interventions
- PROCEDURE
-
Assessment of Distress
Undergo psychological distress screening
- OTHER
-
Consultation Visit
Attend consultations
- OTHER
-
Nutritional Assessment
Undergo malnutrition screening
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Supportive Care
Receive access to bladder cancer ENST
- OTHER
-
Supportive Care
Attend virtual support group meetings
Sponsors & Collaborators
-
Roswell Park Cancer Institute
lead OTHER
Principal Investigators
-
Saby George, MD · Roswell Park Cancer Institute
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-12
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
NCT06774131 ·Status: RECRUITING ·Phase: PHASE3
-
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT04164082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
NCT04579224 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
NCT02603432 ·Status: COMPLETED ·Phase: PHASE3
-
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
NCT05687721 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
NCT04963153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
NCT06488222 ·Status: RECRUITING ·Phase: PHASE2
-
First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
NCT03324282 ·Status: TERMINATED ·Phase: PHASE2
-
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
NCT07261592 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
NCT05756569 ·Status: RECRUITING ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
NCT02944357 ·Status: WITHDRAWN ·Phase: NA
-
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
NCT03244384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
NCT06331299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
NCT04586244 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
NCT05868265 ·Status: RECRUITING ·Phase: PHASE2
-
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
NCT06809140 ·Status: RECRUITING ·Phase: PHASE2
-
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
NCT04235764 ·Status: RECRUITING
-
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
NCT03617913 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
NCT01314664 ·Status: TERMINATED
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT00028756 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Image-Guided Tumorboost of Bladder Cancer
NCT00963404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
NCT06764095 ·Status: RECRUITING ·Phase: PHASE4